Public annual accounts

MEDIPIM financials

A multi-period view of the public annual-account figures reported for MEDIPIM, with comparable measures and links to available source documents.

Company overview
Registry number

0545879079

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

2025 versus 2024

Operating line
€810,044

+16%

EBITDA
€409,052

+33.1%

Total assets
€1,281,686

+2%

Equity
€507,169

+18%

EBITDA margin +50.5% · Equity ratio +39.6%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO
Fiscal year
Gross margin
EBITDA
Total assets
Equity
Filing
202531 Dec 2025€810,044€409,052€1,281,686€507,169-
202431 Dec 2024€698,573€307,253€1,256,300€429,813-
Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report